Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment
Crossref DOI link: https://doi.org/10.1007/s40120-019-00166-3
Published Online: 2019-12-12
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vanderstichele, Hugo Marcel
Teunissen, Charlotte E.
Vanmechelen, Eugeen
Text and Data Mining valid from 2019-12-01
Version of Record valid from 2019-12-12
Article History
Received: 12 September 2019
First Online: 12 December 2019